4503 Stock Overview
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Astellas Pharma Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,785.00 |
| 52 Week High | JP¥1,978.00 |
| 52 Week Low | JP¥1,426.00 |
| Beta | 0.29 |
| 11 Month Change | 2.76% |
| 3 Month Change | 7.92% |
| 1 Year Change | -7.68% |
| 33 Year Change | -7.54% |
| 5 Year Change | 0.82% |
| Change since IPO | 203.57% |
Recent News & Updates
Astellas Pharma Inc.'s (TSE:4503) Earnings Haven't Escaped The Attention Of Investors
Oct 15
Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00
Sep 24Recent updates
Astellas Pharma Inc.'s (TSE:4503) Earnings Haven't Escaped The Attention Of Investors
Oct 15Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00
Sep 24Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00
Sep 03Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00
Aug 20Earnings Beat: Astellas Pharma Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 04Astellas Pharma's (TSE:4503) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 26Astellas Pharma (TSE:4503) Is Paying Out A Larger Dividend Than Last Year
Jul 11Is Astellas Pharma (TSE:4503) A Risky Investment?
Jun 14Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear
May 02Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 29Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price
Feb 29Shareholder Returns
| 4503 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 2.0% | 0.05% | -0.7% |
| 1Y | -7.7% | 18.0% | 17.4% |
Return vs Industry: 4503 underperformed the JP Pharmaceuticals industry which returned 18% over the past year.
Return vs Market: 4503 underperformed the JP Market which returned 17.4% over the past year.
Price Volatility
| 4503 volatility | |
|---|---|
| 4503 Average Weekly Movement | 4.0% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in JP Market | 10.4% |
| 10% least volatile stocks in JP Market | 3.6% |
Stable Share Price: 4503 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4503's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1923 | 14,754 | Naoki Okamura | www.astellas.com |
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants.
Astellas Pharma Inc. Fundamentals Summary
| 4503 fundamental statistics | |
|---|---|
| Market cap | JP¥3.16t |
| Earnings (TTM) | JP¥21.52b |
| Revenue (TTM) | JP¥1.70t |
148.7x
P/E Ratio1.9x
P/S RatioIs 4503 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4503 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.70t |
| Cost of Revenue | JP¥314.67b |
| Gross Profit | JP¥1.39t |
| Other Expenses | JP¥1.37t |
| Earnings | JP¥21.52b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 12.00 |
| Gross Margin | 81.51% |
| Net Profit Margin | 1.26% |
| Debt/Equity Ratio | 59.2% |
How did 4503 perform over the long term?
See historical performance and comparisonDividends
4.1%
Current Dividend Yield583%
Payout RatioDoes 4503 pay a reliable dividends?
See 4503 dividend history and benchmarks| Astellas Pharma dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 24 days |
| Days until Dividend pay date | 42 days |
Does 4503 pay a reliable dividends?
See 4503 dividend history and benchmarks